Data / Drug companies / Ivermectin
Ivermectin: 33 companies and 38 products in the FDA NDC directory
Ivermectin is listed in the FDA National Drug Code Directory by 33 companies, with 38 products in commercial distribution. 31 of the products (81.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are lotion; tablet; cream, and the newest product started marketing on October 18, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 33
- Products
- 38
- Generic (ANDA) products
- 31 (81.6%)
- Application numbers
- 15
- Routes
- Topical, Oral
- Brand names
- Sklice, Stromectol, Vivoclear Lvermectin Lice Treatment, Rid One and Done, Soolantra
- openFDA record search
- api.fda.gov
Companies that list ivermectin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Advagen Pharma Ltd | 2 | tablet | Generic drugs (ANDA) | January 22, 2025 |
| Azurity Pharmaceuticals, Inc. | 2 | lotion | New drug applications (NDA) | August 11, 2026 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | lotion | Generic drugs (ANDA) | June 20, 2025 |
| Viona Pharmaceuticals Inc | 2 | tablet; cream | Generic drugs (ANDA) | February 27, 2026 |
| Zydus Lifesciences Limited | 2 | tablet; cream | Generic drugs (ANDA) | February 27, 2026 |
| A-S Medication Solutions | 1 | tablet | Generic drugs (ANDA) | November 15, 2014 |
| Actavis Pharma, Inc. | 1 | cream | Generic drugs (ANDA) | October 14, 2019 |
| Ajanta Pharma USA Inc. | 1 | tablet | Generic drugs (ANDA) | April 7, 2026 |
| Amerisource Bergen | 1 | lotion | Generic drugs (ANDA) | April 3, 2026 |
| Asclemed USA, Inc. | 1 | tablet | Generic drugs (ANDA) | November 15, 2014 |
| Belmora LLC | 1 | lotion | Generic drugs (ANDA) | August 12, 2024 |
| Bryant Ranch Prepack | 1 | cream | Generic drugs (ANDA) | October 14, 2019 |
| Bryant Ranch Prepack | 1 | cream | Generic drugs (ANDA) | January 8, 2024 |
| Bryant Ranch Prepack | 1 | cream | Generic drugs (ANDA) | January 8, 2024 |
| Dr. Reddy's Laboratories Inc. | 1 | tablet | Generic drugs (ANDA) | November 1, 2024 |
| Edenbridge Pharmaceuticals LLC. | 1 | tablet | Generic drugs (ANDA) | November 15, 2014 |
| Epic Pharma, LLC | 1 | tablet | Generic drugs (ANDA) | December 15, 2024 |
| Fast Sold LLC | 1 | lotion | Generic drugs (ANDA) | September 25, 2026 |
| Galderma Laboratories, L.P. | 1 | cream | New drug applications (NDA) | January 1, 2015 |
| Guangxi Zhouyu Xingchen Technology Co., Ltd. | 1 | lotion | Over the counter monograph drugs | September 25, 2026 |
| Mayne Pharma | 1 | cream | Authorized generics (NDA) | January 8, 2024 |
| Merck Sharp & Dohme LLC | 1 | tablet | New drug applications (NDA) | November 22, 1996 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | November 15, 2014 |
| Oystershell Consumer Health Inc | 1 | lotion | Generic drugs (ANDA) | August 2, 2024 |
| Padagis Israel Pharmaceuticals Ltd | 1 | cream | Generic drugs (ANDA) | January 8, 2024 |
| Rite Aid Corporation | 1 | lotion | Generic drugs (ANDA) | May 6, 2020 |
| Shenzhen Xuyan Technology Co., Ltd. | 1 | lotion | Over the counter monograph drugs | June 12, 2026 |
| Sun Pharmaceutical Industries, Inc. | 1 | lotion | Generic drugs (ANDA) | May 6, 2020 |
| Walgreen Company | 1 | lotion | Generic drugs (ANDA) | May 6, 2020 |
| Walmart Inc. | 1 | lotion | Generic drugs (ANDA) | December 27, 2022 |
| Whitezenith Inc | 1 | lotion | Generic drugs (ANDA) | October 18, 2026 |
| Yunqi Cosmetics (Shenzhen) Co., Ltd | 1 | lotion/shampoo | Over the counter monograph drugs | July 15, 2026 |
| Yyba Corp | 1 | lotion | Generic drugs (ANDA) | August 3, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Lotion | 16 | 42.1% |
| Tablet | 12 | 31.6% |
| Cream | 9 | 23.7% |
| Lotion/shampoo | 1 | 2.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 31 | 81.6% |
| Over the counter monograph drugs | 3 | 7.9% |
| New drug applications (NDA) | 3 | 7.9% |
| Authorized generics (NDA) | 1 | 2.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antiparasitic | 38 |
| Pediculicide | 38 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.